Biotechnology
June 1, 2018
Trial Results For Schizophrenia Drug From Minerva Neurosciences Inc (NASDAQ: NERV) Boost The Company’s Shares Minerva Neurosciences Inc (NASDAQ: NERV) has every reason to celebrate. The clinical-stage […]
May 23, 2018
Immunomedics, Inc. (NASDAQ:IMMU) Presents Promising Data Of Sacituzumab Govitecan For Treatment Of Metastatic Breast Cancer In Women Immunomedics, Inc. (NASDAQ:IMMU) has announced promising data of Sacituzumab Govitecan, […]
May 19, 2018
Alpine Immune Sciences Inc (NASDAQ:ALPN) Is Focusing On INDs For ALPN-101 To Cure Autoimmune/Inflammatory Conditions Alpine Immune Sciences Inc (NASDAQ:ALPN) recently announced its corporate update and financial […]